<DOC>
	<DOCNO>NCT01666613</DOCNO>
	<brief_summary>The purpose study look drug level AZD8683 blood drug administer different way - orally , intravenously inhale ( two different device ) , healthy subject</brief_summary>
	<brief_title>A Study Healthy Subjects Investigate Pharmacokinetics AZD8683 When Administered Different Ways</brief_title>
	<detailed_description>A Phase I , Single-centre , Open-label , Partly Randomised , Cross-over Single Dose Study Healthy Volunteers Evaluate Absolute Pulmonary Bioavailability AZD8683 Administered Inhaled via New Dry Powder Inhaler via Turbuhalerâ„¢</detailed_description>
	<criteria>Healthy male woman nonchildbearing potential age 1845 year inclusive suitable vein cannulation repeat vein puncture Have body mass index ( BMI ) 19 30 kg/m2 ( inclusive ) weight 50 100 kg ( inclusive ) Be able inhale inhaler device use study . History clinically significant disease disorder Current smokers Any clinically relevant abnormal finding physical examination laboratory value .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Phase I , Healthy volunteer , pharmacokinetics</keyword>
	<keyword>Bioavailability</keyword>
	<keyword>AUC</keyword>
</DOC>